You have 9 free searches left this month | to do more

gemcitabine

Gemcitabine is a drug used to treat Pancreatic Cancer, Breast Cancer, Bladder Cancer, and other conditions. Gemcitabine is being actively studied in 339 studies and prior, has been studied in 510.

Top SponsorsTop SitesTop Investigators
Eli Lilly and CompanyFor additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.Xian-Jun Yu
Hoffmann-La RocheMemorial Sloan Kettering Cancer CenterJun Ma, MD
M.D. Anderson Cancer CenterMassachusetts General HospitalPD Dr. med. Volker Heinemann
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Recurrent or Metastatic
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
2022-03-23
Mar 23, 2022
P
Recruiting
  • Breast Cancer
  • Breast Neoplasms
  • Gemcitabine
  • +2 more
  • Charlottesville, Virginia
    University of Virginia
2021-10-29
Oct 29, 2021
A
Active, not recruiting
  • Cholangiocarcinoma
  • +3 more
  • Durvalumab
  • +3 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
2021-10-14
Oct 14, 2021
G
Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Seoul, Daehak-ro, Jongno-gu, Korea, Republic of
    Seoul National University Hospital
2021-11-18
Nov 18, 2021
J
Not yet recruiting
  • Pancreatic Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2022-01-23
Jan 23, 2022
S
Completed
  • Metastatic Pancreatic Adenocarcinoma
  • Madrid, Spain
    Spanish Cooperative for Digestive Tumour Therapy (TTD)
2021-08-11
Aug 11, 2021
R
Not yet recruiting
  • Pancreatic Cancer
  • Shanghai, Shanghai, China
    Ruijin Hospital Shanghai Jiaotong University School of Medicine
2022-01-10
Jan 10, 2022
H
Completed
  • Pancreatic Cancer
  • +4 more
  • Ascorbic Acid
  • +3 more
  • Scottsdale, Arizona
    HonorHealth Research Institute
2022-02-10
Feb 10, 2022
D
Recruiting
  • Pancreatic Cancer
  • Gemcitabine
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-12-28
Dec 28, 2021
U
Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Gemcitabine
  • Aurora, Colorado
    Children's Hospital Colorado
2022-01-31
Jan 31, 2022
U
Completed
  • Cervical Carcinoma
  • Intensity Modulated Radiation Therapy (IMRT)
  • +2 more
  • La Jolla, California
    Moores UC San Diego Cancer Center
2022-02-16
Feb 16, 2022
H
Active, not recruiting
  • Unresectable Pancreatic Carcinoma
  • Herlev, Denmark
  • +1 more
2022-03-15
Mar 15, 2022
P
Not yet recruiting
  • Pancreatic Cancer Metastatic
  • +2 more
  • (no location specified)
2022-02-21
Feb 21, 2022
M
Recruiting
  • Ewing Sarcoma
  • Ewing-Like Sarcoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
2022-03-02
Mar 2, 2022
U
Recruiting
  • Urothelial Cancer of Renal Pelvis
  • Urothelial Carcinoma Ureter
  • sterile water irrigation
  • Gemcitabine
  • Dallas, Texas
    University of Texas Southwestern Medical Center
2021-11-30
Nov 30, 2021
A
Completed
  • Advanced Solid Tumors
  • veliparib (ABT-888)
  • +2 more
  • (no location specified)
2021-07-29
Jul 29, 2021
S
Recruiting
  • Pancreas Cancer
  • New York, New York
    Columbia University Medical Center
2022-02-03
Feb 3, 2022
J
Recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Gemcitabine
  • +2 more
  • Beverly Hills, California
  • +1 more
2022-02-07
Feb 7, 2022
V
Active, not recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Sarcoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
2021-12-03
Dec 3, 2021
M
C
Recruiting
  • Recurrent Pancreatic Cancer
  • Shanghai, China
    Changhai Hospital
2021-05-25
May 25, 2021
S
Completed
  • Lung Cancer
  • Nashville, Tennessee
    Tennessee Oncology
2022-02-21
Feb 21, 2022
D
Not yet recruiting
  • Soft Tissue Sarcoma
  • +5 more
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
2021-12-20
Dec 20, 2021
I